Sodium valproate and valproic acid appear to lower barbiturate metabolism; hence, barbiturate blood stages must be monitored and appropriate dosage adjustments made as indicated.pentobarbital will decrease the extent or outcome of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of